Intelligent Bio Solutions Inc. (INBS)

USD 1.27

(-6.62%)

Total Debt Summary of Intelligent Bio Solutions Inc.

  • Intelligent Bio Solutions Inc.'s latest annual total debt in 2024 was 871.44 Thousand USD , down -34.76% from previous year.
  • Intelligent Bio Solutions Inc.'s latest quarterly total debt in 2024 FY was 871.44 Thousand USD , down -34.76% from previous quarter.
  • Intelligent Bio Solutions Inc. reported annual total debt of 1.33 Million USD in 2023, down 0.0% from previous year.
  • Intelligent Bio Solutions Inc. reported annual total debt of - USD in 2022, down 0.0% from previous year.
  • Intelligent Bio Solutions Inc. reported quarterly total debt of 933.47 Thousand USD for 2024 Q3, down -13.64% from previous quarter.
  • Intelligent Bio Solutions Inc. reported quarterly total debt of 871.44 Thousand USD for 2024 FY, down -34.76% from previous quarter.

Annual Total Debt Chart of Intelligent Bio Solutions Inc. (2024 - 2017)

Historical Annual Total Debt of Intelligent Bio Solutions Inc. (2024 - 2017)

Year Total Debt Total Debt Growth
2024 871.44 Thousand USD -34.76%
2023 1.33 Million USD 0.0%
2022 - USD 0.0%
2021 - USD -100.0%
2020 5.13 Million USD 0.05%
2019 5.13 Million USD 6.02%
2018 4.83 Million USD 36.94%
2017 3.53 Million USD 0.0%

Peer Total Debt Comparison of Intelligent Bio Solutions Inc.

Name Total Debt Total Debt Difference
Bionano Genomics, Inc. 87.94 Million USD 99.009%
Prenetics Global Limited 2.36 Million USD 63.221%
Star Equity Holdings, Inc. 3.6 Million USD 75.854%
CareDx, Inc 34.22 Million USD 97.453%
Exact Sciences Corporation 2.55 Billion USD 99.966%
Exagen Inc. 23.72 Million USD 96.326%
Inotiv, Inc. 417.64 Million USD 99.791%
Guardant Health, Inc. 1.35 Billion USD 99.936%
Biodesix, Inc. 60.69 Million USD 98.564%
BioNexus Gene Lab Corp. 133.39 Thousand USD -553.278%
Precipio, Inc. 1.11 Million USD 21.914%
iSpecimen Inc. 196.24 Thousand USD -344.059%
Natera, Inc. 441.99 Million USD 99.803%
Aspira Women's Health Inc. 2.26 Million USD 61.543%
Standard BioTools Inc. 98.21 Million USD 99.113%
23andMe Holding Co. 76.51 Million USD 98.861%
Castle Biosciences, Inc. 15.31 Million USD 94.308%
Personalis, Inc. 48.96 Million USD 98.22%
Aclaris Therapeutics, Inc. 426 Thousand USD -104.563%
Applied DNA Sciences, Inc. 1.23 Million USD 29.595%
OpGen, Inc. 13.04 Million USD 93.319%
T2 Biosystems, Inc. 49.49 Million USD 98.239%
Myriad Genetics, Inc. 145 Million USD 99.399%
ICON Public Limited Company 3.93 Billion USD 99.978%
NeoGenomics, Inc. 611.67 Million USD 99.858%
Star Equity Holdings, Inc. 3.6 Million USD 75.854%
IDEXX Laboratories, Inc. 947.88 Million USD 99.908%
RadNet, Inc. 1.49 Billion USD 99.942%
MDxHealth SA 41.26 Million USD 97.888%
Psychemedics Corporation 2.29 Million USD 62.078%
Illumina, Inc. 2.26 Billion USD 99.961%
Check-Cap Ltd. - USD -Infinity%
Twist Bioscience Corporation 94.06 Million USD 99.074%
DarioHealth Corp. 29.54 Million USD 97.05%
Fulgent Genetics, Inc. 14.9 Million USD 94.154%
Sera Prognostics, Inc. 1.85 Million USD 53.098%
ENDRA Life Sciences Inc. 394.4 Thousand USD -120.952%
OPKO Health, Inc. 326.56 Million USD 99.733%
Medpace Holdings, Inc. 142.12 Million USD 99.387%
Neogen Corporation 906.23 Million USD 99.904%
Prenetics Global Limited 2.36 Million USD 63.221%
Mainz Biomed B.V. 7.42 Million USD 88.257%
bioAffinity Technologies, Inc. 1.57 Million USD 44.798%
Trinity Biotech plc 67.42 Million USD 98.708%
Neuronetics, Inc. 62.47 Million USD 98.605%
Sotera Health Company 2.32 Billion USD 99.963%
bioAffinity Technologies, Inc. 1.57 Million USD 44.798%